Cardiac fibrosis
NG Frangogiannis - Cardiovascular research, 2021 - academic.oup.com
Myocardial fibrosis, the expansion of the cardiac interstitium through deposition of
extracellular matrix proteins, is a common pathophysiologic companion of many different …
extracellular matrix proteins, is a common pathophysiologic companion of many different …
[HTML][HTML] Ferroptosis and its role in cardiomyopathy
D Li, W Pi, Z Sun, X Liu, J Jiang - Biomedicine & Pharmacotherapy, 2022 - Elsevier
Heart disease is the leading cause of death worldwide. Cardiomyopathy is a disease
characterized by the heart muscle damage, resulting heart in a structurally and functionally …
characterized by the heart muscle damage, resulting heart in a structurally and functionally …
Mutant lamins cause nuclear envelope rupture and DNA damage in skeletal muscle cells
Mutations in the LMNA gene, which encodes the nuclear envelope (NE) proteins lamins A/C,
cause Emery–Dreifuss muscular dystrophy, congenital muscular dystrophy and other …
cause Emery–Dreifuss muscular dystrophy, congenital muscular dystrophy and other …
The regulatory roles of p53 in cardiovascular health and disease
H Men, H Cai, Q Cheng, W Zhou, X Wang… - Cellular and Molecular …, 2021 - Springer
Cardiovascular disease (CVD) remains the leading cause of mortality globally, so further
investigation is required to identify its underlying mechanisms and potential targets for its …
investigation is required to identify its underlying mechanisms and potential targets for its …
Genomic reorganization of lamin-associated domains in cardiac myocytes is associated with differential gene expression and DNA methylation in human dilated …
Rationale: LMNA (Lamin A/C), a nuclear membrane protein, interacts with genome through
lamin-associated domains (LADs) and regulates gene expression. Mutations in the LMNA …
lamin-associated domains (LADs) and regulates gene expression. Mutations in the LMNA …
Targeting DNA damage response in cardiovascular diseases: from pathophysiology to therapeutic implications
Cardiovascular diseases (CVDs) arise from a complex interplay among genomic, proteomic,
and metabolomic abnormalities. Emerging evidence has recently consolidated the presence …
and metabolomic abnormalities. Emerging evidence has recently consolidated the presence …
Regulated cell death pathways in cardiomyopathy
S Sheng, J Li, X Hu, Y Wang - Acta Pharmacologica Sinica, 2023 - nature.com
Heart disease is a worldwide health menace. Both intractable primary and secondary
cardiomyopathies contribute to malignant cardiac dysfunction and mortality. One of the key …
cardiomyopathies contribute to malignant cardiac dysfunction and mortality. One of the key …
Recent findings related to cardiomyopathy and genetics
T Yamada, S Nomura - International Journal of Molecular Sciences, 2021 - mdpi.com
With the development and advancement of next-generation sequencing (NGS), genetic
analysis is becoming more accessible. High-throughput genetic studies using NGS have …
analysis is becoming more accessible. High-throughput genetic studies using NGS have …
Precision Medicine in the Management of Dilated Cardiomyopathy: JACC State-of-the-Art Review
D Fatkin, IG Huttner, JC Kovacic, JG Seidman… - Journal of the American …, 2019 - jacc.org
Precision medicine promises to dramatically improve patient outcomes and reduce health
care costs through a shift in focus from disease treatment to prevention and individualized …
care costs through a shift in focus from disease treatment to prevention and individualized …
Loss of function of the nuclear envelope protein LEMD2 causes DNA damage–dependent cardiomyopathy
XM Caravia, A Ramirez-Martinez, P Gan… - The Journal of …, 2022 - Am Soc Clin Investig
Mutations in nuclear envelope proteins (NEPs) cause devastating genetic diseases, known
as envelopathies, that primarily affect the heart and skeletal muscle. A mutation in the NEP …
as envelopathies, that primarily affect the heart and skeletal muscle. A mutation in the NEP …